Defibrillator Pacemaker Tachycardia 
Dr. Smith's ECG Blog
APRIL 2, 2024
He was defibrillated, but they also noticed that he was being internally defibrillated and then found that he had an implantable ICD. He was unidentified and there were no records available After 7 shocks, he was successfully defibrillated and brought to the ED. Tachycardia exaggerates ST Elevation in LBBB and Paced rhythm 5.
Med Page Today
MAY 20, 2024
(MedPage Today) -- BOSTON -- A leadless pacemaker reliably communicated with a subcutaneous implantable cardioverter-defibrillator (S-ICD) to deliver anti-tachycardia (ATP) and bradycardia pacing, the MODULAR ATP study showed. In terms of safety.
ECG Guru
DECEMBER 21, 2023
If ventricular tachycardia occurs in an Implantable Cardioverter Defibrillator (ICD) wearer, the ICD can combat this with 2 different forms of therapy, provided these are activated (which can be done using a programming device). First, the ICD attempts to override the tachycardia. The fastest pacemaker gets control of the heart.
ECG Guru
DECEMBER 18, 2023
If ventricular tachycardia occurs in an Implantable Cardioverter Defibrillator (ICD) wearer, the ICD can combat this with 2 different forms of therapy, provided these are activated (which can be done using a programming device). First, the ICD attempts to override the tachycardia. The fastest pacemaker gets control of the heart.
Dr. Smith's ECG Blog
JANUARY 2, 2025
Place temporary pacemaker 3. Because she has cardiomyopathy and ventricular dysrhythmias, the pacer included an Implanted Cardioverter-Defibrillator (ICD) Echo 6 days later after CRT: Normal estimated left ventricular ejection fraction. Even with tachycardia and a paced QRS duration of ~0.16 No wall motion abnormality.
Frontiers in Cardiovascular Medicine
APRIL 3, 2025
Primary endpoint was the incidence of patients with new onset supraventricular arrhythmia (AF, atrial flutter or any supraventricular tachycardia) lasting >30s, post PFO closure.ResultsA total of 59 patients met the inclusion criteria.
HeartRhythm
MAY 15, 2024
Subcutaneous implantable cardioverter defibrillators (S-ICD) are a safe and effective alternative to transvenous ICDs for patients at risk for ventricular tachyarrhythmias.1 1 A major limitation of an S-ICD is its inability to deliver anti-tachycardia pacing (ATP) for monomorphic ventricular tachycardia (MMVT).
Expert insights. Personalized for you.
132 
Let's personalize your content